USD 5.09
(-5.39%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 119.86 Million USD | -14.56% |
2022 | 140.29 Million USD | -22.78% |
2021 | 181.68 Million USD | 921.4% |
2020 | 17.78 Million USD | 8.7% |
2019 | 16.36 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 105.28 Million USD | -12.16% |
2024 Q2 | 93.34 Million USD | -11.34% |
2023 Q2 | 104.52 Million USD | -13.68% |
2023 Q4 | 119.86 Million USD | -9.23% |
2023 Q1 | 121.09 Million USD | -13.69% |
2023 FY | 119.86 Million USD | -14.56% |
2023 Q3 | 132.05 Million USD | 26.33% |
2022 Q2 | 164.05 Million USD | -8.85% |
2022 FY | 140.29 Million USD | -22.78% |
2022 Q4 | 140.29 Million USD | -6.89% |
2022 Q1 | 179.97 Million USD | -0.94% |
2022 Q3 | 150.67 Million USD | -8.15% |
2021 FY | 181.68 Million USD | 921.4% |
2021 Q2 | 12.11 Million USD | -96.5% |
2021 Q3 | 193.36 Million USD | 1495.81% |
2021 Q1 | 346.35 Million USD | 1847.11% |
2021 Q4 | 181.68 Million USD | -6.04% |
2020 FY | 17.78 Million USD | 8.7% |
2020 Q3 | 346.47 Million USD | 0.0% |
2020 Q4 | 17.78 Million USD | -94.87% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | 16.36 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Abbott Laboratories | 73.21 Billion USD | 99.836% |
Allurion Technologies Inc. | 71.71 Million USD | -67.146% |
Artivion, Inc. | 792.39 Million USD | 84.873% |
Avanos Medical, Inc. | 1.69 Billion USD | 92.918% |
Butterfly Network, Inc. | 304.27 Million USD | 60.607% |
Butterfly Network, Inc. | 304.27 Million USD | 60.607% |
Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 99.025% |
Boston Scientific Corporation | 35.13 Billion USD | 99.659% |
CONMED Corporation | 2.3 Billion USD | 94.789% |
Edwards Lifesciences Corporation | 9.36 Billion USD | 98.72% |
Paragon 28, Inc. | 340.69 Million USD | 64.818% |
Glaukos Corporation | 940.41 Million USD | 87.254% |
Globus Medical, Inc. | 5.08 Billion USD | 97.643% |
Inspire Medical Systems, Inc. | 676.81 Million USD | 82.29% |
Integer Holdings Corporation | 2.94 Billion USD | 95.927% |
Medtronic plc | 89.98 Billion USD | 99.867% |
Myomo, Inc. | 14.58 Million USD | -722.024% |
Nevro Corp. | 635.71 Million USD | 81.145% |
Owlet, Inc. | 44.12 Million USD | -171.659% |
Penumbra, Inc. | 1.55 Billion USD | 92.298% |
Smith & Nephew plc | 9.98 Billion USD | 98.8% |
Sonendo, Inc. | 78.16 Million USD | -53.357% |
STERIS plc | 11.06 Billion USD | 98.917% |
Stryker Corporation | 39.91 Billion USD | 99.7% |
Vapotherm, Inc. | 77.61 Million USD | -54.43% |
Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 99.442% |